Humatrope Enhances Fitness in Adult GHD: 2-Year Study of 128 U.S. Males
Reading Time: < 1 minute Introduction Growth hormone deficiency (GHD) in adulthood, particularly among American males, represents a significant public health concern. With sedentary lifestyles, rising obesity rates (affecting over 40% of U.S. adult males per CDC data), and an aging population, GHD exacerbates sarcopenia, diminished aerobic capacity, and metabolic dysregulation. Humatrope (somatropin), a recombinant human growth hormone (rhGH), has emerged as a cornerstone therapy for restoring physiological homeostasis. This 2-year kinesiological study evaluates Humatrope's impact on physical fitness metrics in 128 American males (aged 35-65 years) diagnosed with adult-onset GHD, providing novel insights into its role in enhancing exercise tolerance, body composition, and functional...


